Josep Tabernero, MD, PhD
Vall d' Hebron Institute of Oncology (VHIO), Barcelona, Spain · Vall d'Hebron Institute of Oncology · Vall d'Hebron University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Josep Tabernero, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:39 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04495621 · MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)Menarini Group · completed · Metastatic Colorectal Cancer · study chair
- Ph3NCT03717038 · Sym004 Versus TAS-102 in Patients With mCRCSymphogen A/S · withdrawn · Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma · principal investigator
- Ph1/Ph2NCT02568046 · Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer PatientsSymphogen A/S · terminated · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT02083653 · Sym004 vs Standard of Care in Subjects With Metastatic Colorectal CancerSymphogen A/S · completed · Metastatic Colorectal Cancer · principal investigator
- Ph1/Ph2NCT01117428 · Sym004 in Patients With Advanced Solid TumorsSymphogen A/S · completed · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT00958386 · Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) · completed · Metastatic Colorectal Cancer · study chair
- Ph2NCT00733889 · A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal CarcinomaSpanish Cooperative Group for the Treatment of Digestive Tumours (TTD) · completed · Esophageal Carcinoma
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.